Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Assets (2020 - 2025)

Oncology Institute (TOI) has disclosed Current Assets for 6 consecutive years, with $110.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 5.44% year-over-year to $110.1 million, compared with a TTM value of $110.1 million through Sep 2025, down 5.44%, and an annual FY2024 reading of $112.4 million, down 21.66% over the prior year.
  • Current Assets was $110.1 million for Q3 2025 at Oncology Institute, up from $104.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $154.1 million in Q4 2021 and bottomed at $287110.0 in Q3 2021.
  • Average Current Assets over 5 years is $105.7 million, with a median of $116.2 million recorded in 2024.
  • The sharpest move saw Current Assets crashed 76.09% in 2021, then soared 49926.47% in 2022.
  • Year by year, Current Assets stood at $154.1 million in 2021, then fell by 15.34% to $130.4 million in 2022, then rose by 10.03% to $143.5 million in 2023, then dropped by 21.66% to $112.4 million in 2024, then dropped by 2.07% to $110.1 million in 2025.
  • Business Quant data shows Current Assets for TOI at $110.1 million in Q3 2025, $104.8 million in Q2 2025, and $106.8 million in Q1 2025.